Nutra Ingredients-usa

1 day ago | nutraingredients-usa.com | Asia Sherman

Initially developed as a consumer bottled water concept, the technology, which produces bubbles invisible to the naked eye, showed potential for broader scientific and commercial applications, but its core mechanisms were not yet fully understood. Recognizing an opportunity, Hydrosome Labs was formally incorporated in 2021, and it began building a multidisciplinary team of researchers, engineers and innovators committed to advancing ultrafine bubble science.

2 days ago | nutraingredients-usa.com | Asia Sherman

The company was founded in 2023 by Eden Banon, who brings a venture capital background advising deep tech start-ups, and Eugénie Pezé-Heidsieck, who holds a PhD in cellular and molecular biology. As two women in their thirties, they say they were drawn to the topics of breastfeeding and infant nutrition and driven by a shared belief that some of the world’s most pressing challenges can be solved at the intersection of deep science and entrepreneurship.

3 days ago | nutraingredients-usa.com | Asia Sherman

Co-founded by microbiome and technology expert Dr. Tim Mak and molecular biologist Dr. Patrick Guye, Trilliome distinguishes itself by isolating bioactive compounds from Asian fruits, offering an alternative to more conventional approaches that rely on generic fibers or common probiotic strains for broad-spectrum applications.

4 days ago | nutraingredients-usa.com | Claudia Adrien

To explore this relationship, researchers from Nankai University and the People’s Hospital of Chongqing Liangjiang examined health and nutrition records from 39,372 participants in the National Health and Nutrition Examination Survey (NHANES), collected between 2003 and 2018. “Emerging research suggests that selenium may have anti-thrombotic properties by influencing platelet function and coagulation factors,” the Chinese researchers wrote in the journal Scientific Reports.

1 week ago | nutraingredients-usa.com | Asia Sherman

The department’s inquiry—launched April 1 through its Bureau of Industry and Security under Section 232 of the Trade Expansion Act of 1962—is focused on whether imports including finished and generic drug products, medical countermeasures and critical inputs like active pharmaceutical ingredients pose a risk to national security. The 232 Docket for pharmaceuticals closed to comments on May 7 with some 240 submissions, including those from supplement industry representatives.